tiprankstipranks
Privi Speciality Chemicals Limited (IN:PRIVISCL)
:PRIVISCL
India Market
Want to see IN:PRIVISCL full AI Analyst Report?

Privi Speciality Chemicals Limited (PRIVISCL) AI Stock Analysis

1 Followers

Top Page

IN:PRIVISCL

Privi Speciality Chemicals Limited

(PRIVISCL)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
₹3,505.00
▲(26.15% Upside)
Action:Reiterated
Date:05/13/26
The score is driven primarily by improving financial performance (growth, stronger earnings, deleveraging, and a FY2026 free-cash-flow rebound). Technicals are moderately supportive with a positive longer-term trend but neutral near-term momentum. Valuation is the main constraint due to a high P/E and a very low dividend yield.
Positive Factors
Revenue Growth Trend
Consistent multi-year revenue growth, including ~10% in FY2026, signals durable demand for its aroma-chemical portfolio. That steady topline expansion supports scale economics, better fixed-cost absorption and provides a firmer base for reinvestment in specialty molecules over the coming months.
Negative Factors
Margin and Cash-Flow Volatility
Historical swings in margins and cash flows (weakness in FY2023 and uneven year-to-year margin quality) indicate sensitivity to raw-material prices, pricing power and working-capital cycles. This volatility reduces earnings predictability and raises execution risk for medium-term planning and investment.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Trend
Consistent multi-year revenue growth, including ~10% in FY2026, signals durable demand for its aroma-chemical portfolio. That steady topline expansion supports scale economics, better fixed-cost absorption and provides a firmer base for reinvestment in specialty molecules over the coming months.
Read all positive factors

Privi Speciality Chemicals Limited (PRIVISCL) vs. iShares MSCI India ETF (INDA)

Privi Speciality Chemicals Limited Business Overview & Revenue Model

Company Description
Privi Speciality Chemicals Limited operates as a manufacturer, supplier, and exporter of aroma and fragrance chemicals in India and internationally. It offers amber fleur, acetates, dihydromyrcenol, ionones, nitriles, sandal wood derivatives, and ...
How the Company Makes Money
PRIVISCL makes money primarily by manufacturing and selling specialty aroma chemicals and chemical intermediates to business customers, including fragrance and flavor houses and manufacturers of consumer products (e.g., personal care, home care, a...

Privi Speciality Chemicals Limited Financial Statement Overview

Summary
Financials are improving: steady revenue growth (~10% in FY2026 vs FY2025), sharply better earnings from the FY2023 trough, meaningful deleveraging in FY2026, and a strong rebound to positive free cash flow. The key risk is historical volatility in margins and cash flows, so durability of the FY2026 step-up remains to be proven.
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
71
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue23.33B25.64B20.92B17.52B16.05B14.02B
Gross Profit9.77B8.14B9.03B6.96B5.98B5.32B
EBITDA5.86B5.02B4.74B3.51B2.07B2.32B
Net Income2.67B3.28B1.87B949.07M222.15M973.80M
Balance Sheet
Total Assets29.57B31.70B27.91B23.43B23.91B21.76B
Cash, Cash Equivalents and Short-Term Investments351.35M1.23B577.31M635.46M271.77M445.19M
Total Debt10.72B10.21B11.43B10.08B10.79B9.30B
Total Liabilities17.11B17.29B16.73B14.01B15.56B13.56B
Stockholders Equity12.40B14.12B11.03B9.24B8.29B8.12B
Cash Flow
Free Cash Flow800.31M1.51B-180.27M2.04B-909.33M-3.04B
Operating Cash Flow2.35B4.71B2.81B3.54B487.59M47.36M
Investing Cash Flow-1.33B-3.34B-2.94B-1.80B-1.33B-3.20B
Financing Cash Flow-1.35B-1.42B386.33M-1.71B723.05M3.33B

Privi Speciality Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2778.50
Price Trends
50DMA
3065.14
Positive
100DMA
2961.12
Positive
200DMA
2831.56
Positive
Market Momentum
MACD
17.90
Positive
RSI
42.52
Neutral
STOCH
12.25
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PRIVISCL, the sentiment is Neutral. The current price of 2778.5 is below the 20-day moving average (MA) of 3263.65, below the 50-day MA of 3065.14, and below the 200-day MA of 2831.56, indicating a neutral trend. The MACD of 17.90 indicates Positive momentum. The RSI at 42.52 is Neutral, neither overbought nor oversold. The STOCH value of 12.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:PRIVISCL.

Privi Speciality Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹124.16B34.560.15%22.01%75.16%
67
Neutral
₹137.91B30.940.48%-0.95%9.51%
64
Neutral
₹156.39B76.500.06%66.49%112.13%
64
Neutral
₹140.69B42.680.26%4.43%1.60%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
₹144.14B66.1337.53%38.70%
55
Neutral
₹43.99B46.140.29%-8.04%-41.66%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:PRIVISCL
Privi Speciality Chemicals Limited
3,178.55
894.56
39.17%
IN:AETHER
Aether Industries Ltd.
1,086.15
345.95
46.74%
IN:ANURAS
Anupam Rasayan India Ltd.
1,373.70
414.93
43.28%
IN:FINEORG
Fine Organic Industries Ltd.
4,588.65
-13.02
-0.28%
IN:LXCHEM
Laxmi Organic Industries Ltd.
158.70
-30.52
-16.13%
IN:VINATIORGA
Vinati Organics Limited
1,330.35
-462.39
-25.79%

Privi Speciality Chemicals Limited Corporate Events

Privi Speciality Chemicals Wins BSE Nod for Three-Way Amalgamation
May 6, 2026
Privi Speciality Chemicals Limited has received a ‘no objection’ observation letter from BSE Limited for its proposed scheme of amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited. This follo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 13, 2026